{"id":"azithromycin-3-days","safety":{"commonSideEffects":[{"rate":"5-10%","effect":"Gastrointestinal disturbance (nausea, diarrhea, abdominal pain)"},{"rate":"2-5%","effect":"Headache"},{"rate":"1-3%","effect":"Vaginitis"},{"rate":"rare","effect":"QT prolongation"},{"rate":"1-2%","effect":"Allergic reactions"}]},"_chembl":{"chemblId":"CHEMBL4299381","moleculeType":"Small molecule","molecularWeight":"749.00"},"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Azithromycin binds to the bacterial 50S ribosomal subunit and inhibits peptide translocation, preventing the formation of the initiation complex and blocking protein synthesis. This bacteriostatic action stops bacterial growth and reproduction. The 3-day formulation refers to a shortened treatment course, typically used for acute infections where efficacy has been demonstrated over this condensed timeframe.","oneSentence":"Azithromycin is a macrolide antibiotic that inhibits bacterial protein synthesis by binding to the 50S ribosomal subunit.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T00:28:04.539Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Acute bacterial infections (respiratory tract infections, otitis media, sinusitis)"},{"name":"Sexually transmitted infections (chlamydia, gonorrhea)"},{"name":"Community-acquired pneumonia"}]},"trialDetails":[{"nctId":"NCT07485010","phase":"PHASE2","title":"Testing a Novel Combination Treatment (Arm D) Versus Standard of Care for Intensive Phase Treatment for Mycobacterium Abscessus Pulmonary Disease in People With or Without Cystic Fibrosis in the Finding the Optimal Regimen for Mycobacterium Abscessus Treatment (FORMaT) Adaptive Platform Trial","status":"NOT_YET_RECRUITING","sponsor":"The University of Queensland","startDate":"2027-04","conditions":"Mycobacterium Abscessus Pulmonary Disease, Mycobacterium Abscessus Infection, Non-Tuberculous Mycobacterial (NTM) Infections","enrollment":300},{"nctId":"NCT05994742","phase":"PHASE3","title":"An Adaptive Multi-arm Trial to Improve Clinical Outcomes Among Children Recovering From Complicated SAM","status":"ACTIVE_NOT_RECRUITING","sponsor":"Queen Mary University of London","startDate":"2024-07-15","conditions":"Severe Acute Malnutrition, HIV, Comorbidities and Coexisting Conditions","enrollment":674},{"nctId":"NCT01233297","phase":"PHASE2","title":"Antibiotic Treatment of Recurrent Episodes of Asthma in Children","status":"ACTIVE_NOT_RECRUITING","sponsor":"Copenhagen Studies on Asthma in Childhood","startDate":"2010-11","conditions":"Childhood Asthma With Acute Exacerbation","enrollment":70},{"nctId":"NCT04069312","phase":"PHASE4","title":"Roflumilast or Azithromycin to Prevent COPD Exacerbations (RELIANCE)","status":"COMPLETED","sponsor":"Johns Hopkins University","startDate":"2020-02-11","conditions":"Chronic Obstructive Pulmonary Disease Severe, Chronic Bronchitis","enrollment":1032},{"nctId":"NCT07443436","phase":"PHASE2","title":"Immunomodulatory Treatment of Interstitial Lung Disease Associated With Surfactant Related Gene Variants","status":"NOT_YET_RECRUITING","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2026-10-01","conditions":"Interstitial Lung Disease","enrollment":30},{"nctId":"NCT05922761","phase":"PHASE2","title":"BElumosudil for Bronchiolitis Obliterans Prevention/Therapy (BEBOP)","status":"RECRUITING","sponsor":"Dana-Farber Cancer Institute","startDate":"2024-05-31","conditions":"Bronchiolitis Obliterans Syndrome, Bronchiolitis Obliterans, Lung Diseases","enrollment":45},{"nctId":"NCT05026749","phase":"PHASE3","title":"Azithromycin Treatment for Respiratory Syncytial Virus-induced Respiratory Failure in Children","status":"RECRUITING","sponsor":"University of Alabama at Birmingham","startDate":"2022-02-27","conditions":"Respiratory Syncytial Virus Infections","enrollment":370},{"nctId":"NCT04294641","phase":"PHASE2","title":"Front Line Ibrutinib Without Corticosteroids for Newly Diagnosed Chronic Graft-versus-Host Disease","status":"COMPLETED","sponsor":"National Cancer Institute (NCI)","startDate":"2021-05-10","conditions":"Chronic GVHD","enrollment":10},{"nctId":"NCT05842681","phase":"NA","title":"Azithromycin in the Management of Patients With Acute Exacerbation of Idiopathic Pulmonary Fibrosis","status":"RECRUITING","sponsor":"Assiut University","startDate":"2023-06-01","conditions":"Idiopathic Pulmonary Fibrosis","enrollment":30},{"nctId":"NCT03083197","phase":"PHASE4","title":"Scrub Typhus Antibiotic Resistance Trial","status":"RECRUITING","sponsor":"University of Oxford","startDate":"2017-10-15","conditions":"Scrub Typhus","enrollment":177},{"nctId":"NCT07296302","phase":"NA","title":"Antibiotic Prophylaxis Versus Placebo in Alveolar Bone Grafting: A Randomized Controlled Trial","status":"NOT_YET_RECRUITING","sponsor":"Agnaldo Rocha de Souza Junior","startDate":"2026-02","conditions":"Alveolar Ridge Augmentation, Bone Grafting, Antibiotic Prophylaxis","enrollment":150},{"nctId":"NCT06223828","phase":"PHASE2, PHASE3","title":"Azithromycin for Critical Asthma - Pediatrics","status":"RECRUITING","sponsor":"Johns Hopkins All Children's Hospital","startDate":"2024-04-02","conditions":"Pediatric Asthma, Critical Illness","enrollment":100},{"nctId":"NCT06468462","phase":"PHASE4","title":"Periodic Presumptive Treatment vs. doxyPEP for STI Control in Kenyan MSM","status":"RECRUITING","sponsor":"University of Washington","startDate":"2025-10-29","conditions":"Gonorrhea Male, Chlamydia (Male), Syphilis Male","enrollment":2900},{"nctId":"NCT06418711","phase":"PHASE3","title":"ICoN-1 Phase 3 Study of the Efficacy and Safety of Treatment With MNKD-101, Clofazimine Inhalation Suspension","status":"TERMINATED","sponsor":"Mannkind Corporation","startDate":"2024-09-11","conditions":"MAC Lung Disease, Treatment Refractory MAC Lung Disease, Mycobacterium Infections, Nontuberculous","enrollment":132},{"nctId":"NCT07148622","phase":"NA","title":"Effects of Different Antibiotic Regimens in Preterm Premature Rupture of Membranes","status":"COMPLETED","sponsor":"Yuzuncu Yil University","startDate":"2024-10-01","conditions":"Preterm Premature Rupture of Membranes (PPROM), Prophylaxis, Perinatal Outcomes","enrollment":40},{"nctId":"NCT03273296","phase":"PHASE4","title":"Effect of Antibiotics on Gut Microbiome and Plasma Metabolome","status":"COMPLETED","sponsor":"Finnish Institute for Health and Welfare","startDate":"2017-10-15","conditions":"Microbial Colonization","enrollment":39},{"nctId":"NCT04310930","phase":"PHASE2, PHASE3","title":"Finding the Optimal Regimen for Mycobacterium Abscessus Treatment","status":"RECRUITING","sponsor":"The University of Queensland","startDate":"2020-03-02","conditions":"Pulmonary Disease Due to Mycobacteria (Diagnosis)","enrollment":300},{"nctId":"NCT06584474","phase":"PHASE4","title":"THE EFFECT OF NEBULIZED AZITHROMYCIN AS THERAPY FOR BRONCHOPULMONARY DYSPLASIA","status":"COMPLETED","sponsor":"Alexandria University","startDate":"2024-10-02","conditions":"Bronchopulmonary Dysplasia, Premature, Ventilation, Mechanical","enrollment":100},{"nctId":"NCT07064278","phase":"NA","title":"Combined Diagnostic Approach for Refractory Mycoplasma Pneumonia in Children","status":"COMPLETED","sponsor":"Children's Hospital of Hebei Province","startDate":"2022-12-01","conditions":"Refractory Mycoplasma Pneumoniae Pneumonia","enrollment":260},{"nctId":"NCT04186247","phase":"PHASE2","title":"Personalized AZithromycin/metronidAZole Therapy in Pediatric Crohn's Disease (CD)","status":"TERMINATED","sponsor":"University of North Carolina, Chapel Hill","startDate":"2021-08-13","conditions":"Crohn Disease, Pediatric Crohns Disease","enrollment":13},{"nctId":"NCT03479736","phase":"","title":"A Study of Fluoroquinolones Exposure and Collagen-Related Serious Adverse Events","status":"COMPLETED","sponsor":"Janssen Research & Development, LLC","startDate":"2017-11-20","conditions":"Retinal Detachment, Achilles Tendon, Aneurysm, Dissecting","enrollment":117911},{"nctId":"NCT05345457","phase":"PHASE4","title":"Outpatient Antibiotics Following Previable Rupture of Membranes (pPPROM) Between 18 0/7 and 22 6/7 Weeks Gestational Age","status":"RECRUITING","sponsor":"University Hospitals Cleveland Medical Center","startDate":"2023-01-13","conditions":"Pregnancy Preterm, Pregnancy Prom, PROM, Preterm (Pregnancy)","enrollment":88},{"nctId":"NCT05028153","phase":"PHASE2","title":"Azithromycin Treatment of Hospitalized Children With Asthmatic Symptoms","status":"RECRUITING","sponsor":"Copenhagen Studies on Asthma in Childhood","startDate":"2022-11-14","conditions":"Childhood Asthma With Acute Exacerbation","enrollment":320},{"nctId":"NCT06917157","phase":"PHASE4","title":"Latency Antibiotics for Previable Rupture Of Membranes Trial","status":"NOT_YET_RECRUITING","sponsor":"The University of Texas Health Science Center, Houston","startDate":"2025-05-01","conditions":"Preterm Prelabor Rupture of Membranes (PPROM)","enrollment":60},{"nctId":"NCT05847322","phase":"NA","title":"Periscope Phase C Bordetella Pertussis Human Challenge Study With Delayed Antibiotic Therapy for 6 Weeks","status":"RECRUITING","sponsor":"University of Southampton","startDate":"2022-12-06","conditions":"Pertussis/Whooping Cough","enrollment":72},{"nctId":"NCT06906757","phase":"NA","title":"Preterm Rupture of Membranes Optimising Antibiotics Trial","status":"NOT_YET_RECRUITING","sponsor":"University of Melbourne","startDate":"2025-09","conditions":"PPROM, Preterm","enrollment":3900},{"nctId":"NCT05461131","phase":"PHASE2","title":"Pertussis Challenge Study in Adults Vaccinated With BPZE1","status":"COMPLETED","sponsor":"ILiAD Biotechnologies","startDate":"2022-06-20","conditions":"Pertussis/Whooping Cough, Bordetella Pertussis, Whooping Cough","enrollment":53},{"nctId":"NCT05972772","phase":"PHASE2, PHASE3","title":"Rickettsia Clearance Study","status":"RECRUITING","sponsor":"Lao-Oxford-Mahosot Hospital Wellcome Trust Research Unit","startDate":"2024-11-01","conditions":"Infectious Disease, Therapeutics","enrollment":72},{"nctId":"NCT06715150","phase":"PHASE4","title":"Non-Surgical Treatment of Peri-implantitis with Systemic Azithromycin or Placebo","status":"NOT_YET_RECRUITING","sponsor":"University of Santiago de Compostela","startDate":"2025-01-10","conditions":"Peri-implantitis","enrollment":52},{"nctId":"NCT04198649","phase":"PHASE3","title":"Effect of Azithromycin on Failure Proportion of Severe Periodontitis Non-surgical Treatment","status":"TERMINATED","sponsor":"University Hospital, Strasbourg, France","startDate":"2021-11-02","conditions":"Severe Chronic Periodontitis","enrollment":6},{"nctId":"NCT02735707","phase":"PHASE3","title":"Randomized, Embedded, Multifactorial Adaptive Platform Trial for Community- Acquired Pneumonia","status":"RECRUITING","sponsor":"UMC Utrecht","startDate":"2016-04-11","conditions":"Community-acquired Pneumonia, Influenza, COVID-19","enrollment":20000},{"nctId":"NCT04527016","phase":"PHASE4","title":"Airway Microbiota Based Treatment of Asthma in Preschool Children","status":"COMPLETED","sponsor":"Children's Hospital of Fudan University","startDate":"2021-10-18","conditions":"Asthma in Children","enrollment":120},{"nctId":"NCT04010539","phase":"PHASE3","title":"A Study Evaluating Efficacy and Safety of Gepotidacin Compared With Ceftriaxone Plus Azithromycin in the Treatment of Uncomplicated Urogenital Gonorrhea","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2019-10-21","conditions":"Gonorrhea","enrollment":628},{"nctId":"NCT04669717","phase":"PHASE4","title":"Antibiotics as Adjuncts to Periodontal Therapy:Pharmacokinetic Considerations and Dosing Strategies","status":"RECRUITING","sponsor":"University of Geneva, Switzerland","startDate":"2021-09-01","conditions":"Periodontal Diseases, Antibiotics, Pharmacokinetics","enrollment":45},{"nctId":"NCT04341727","phase":"PHASE3","title":"Hydroxychloroquine,Hydroxychloroquine,Azithromycin in the Treatment of SARS CoV-2 Infection","status":"TERMINATED","sponsor":"Washington University School of Medicine","startDate":"2020-04-04","conditions":"Coronavirus Infection","enrollment":30},{"nctId":"NCT06332027","phase":"NA","title":"Accuracy of Hystro-Salpingo-Foam-Sonography (HYFOSY) as Tubal Patency Test in Comparison to Laparoscopy in Infertile Patients","status":"NOT_YET_RECRUITING","sponsor":"Sohag University","startDate":"2024-04-01","conditions":"Infertility, Female","enrollment":122},{"nctId":"NCT01444469","phase":"PHASE4","title":"AZithromycin Against pLacebo in Exacerbations of Asthma","status":"COMPLETED","sponsor":"Imperial College London","startDate":"2011-09","conditions":"Asthma","enrollment":199},{"nctId":"NCT06199440","phase":"PHASE1, PHASE2","title":"Azithromycin Versus Doxycycline on Restistin Level in Periodontitis Patients With Type 2 Diabetes","status":"COMPLETED","sponsor":"King Abdulaziz University","startDate":"2022-06-01","conditions":"Periodontal Diseases, Type 2 Diabetes","enrollment":15},{"nctId":"NCT06170983","phase":"NA","title":"Skin Inflammation and PK of Azithromycin","status":"NOT_YET_RECRUITING","sponsor":"Medical University of Vienna","startDate":"2024-01-01","conditions":"Skin Infection","enrollment":36},{"nctId":"NCT03431168","phase":"PHASE2","title":"A Novel Regimen to Prevent Malaria and STI in Pregnant Women With HIV","status":"COMPLETED","sponsor":"University of Alabama at Birmingham","startDate":"2018-03-07","conditions":"HIV, Pregnancy Malaria, Sexually Transmitted Infection","enrollment":308},{"nctId":"NCT05506371","phase":"NA","title":"Effects of Azithromycin as an Adjunct to Scaling and Root Planning in the Treatment of Periodontitis","status":"COMPLETED","sponsor":"Ukrainian Medical Stomatological Academy","startDate":"2017-09-16","conditions":"Periodontitis","enrollment":50},{"nctId":"NCT06093360","phase":"","title":"Flapless Surgical Treatment of Peri-implantitis","status":"COMPLETED","sponsor":"Universidad Complutense de Madrid","startDate":"2018-01-01","conditions":"Peri-Implantitis","enrollment":117},{"nctId":"NCT03854929","phase":"PHASE4","title":"Ciprofloxacin Versus Azithromycin for Children Hospitalised With Dysentery","status":"COMPLETED","sponsor":"Oxford University Clinical Research Unit, Vietnam","startDate":"2019-12-11","conditions":"Dysentery, Shigella, Shigellosis, Diarrhea","enrollment":364},{"nctId":"NCT04336332","phase":"PHASE2","title":"Randomized Comparison of Combination Azithromycin and Hydroxychloroquine vs. Hydroxychloroquine Alone for the Treatment of Confirmed COVID-19","status":"TERMINATED","sponsor":"Rutgers, The State University of New Jersey","startDate":"2020-04-01","conditions":"SARS-CoV-2, COVID-19","enrollment":75},{"nctId":"NCT01769027","phase":"PHASE2","title":"Antibiotic Treatment and Intravenous Immunoglobulin Trial for PANDAS","status":"WITHDRAWN","sponsor":"CNS Onlus","startDate":"2013-06","conditions":"Pandas","enrollment":""},{"nctId":"NCT05629468","phase":"PHASE3","title":"Comparing Efficacy of Azithromycin and Probiotics for Treatment of Acne Vulgaris","status":"COMPLETED","sponsor":"Pak Emirates Military Hospital","startDate":"2021-10-15","conditions":"Acne Vulgaris","enrollment":75},{"nctId":"NCT03683667","phase":"PHASE2, PHASE3","title":"Protein Plus: Improving Infant Growth Through Diet and Enteric Health","status":"COMPLETED","sponsor":"Johns Hopkins Bloomberg School of Public Health","startDate":"2018-09-23","conditions":"Stunting, Malnutrition; Protein, Enteric Pathogens","enrollment":5283},{"nctId":"NCT03629288","phase":"NA","title":"Efficacy of Azithromycin as an Adjunct to Non-Surgical Periodontal Treatment","status":"COMPLETED","sponsor":"Universidad Nacional Andres Bello","startDate":"2016-03-01","conditions":"Periodontitis","enrollment":18},{"nctId":"NCT03208179","phase":"PHASE3","title":"Improving PRegnancy Outcomes With Intermittent preVEntive Treatment in Africa","status":"COMPLETED","sponsor":"Liverpool School of Tropical Medicine","startDate":"2018-03-29","conditions":"Pregnancy, Malaria in Pregnancy, Malaria","enrollment":4680},{"nctId":"NCT05398055","phase":"PHASE3","title":"Efficacy of Azithromycin Plus Doxycycline Versus Doxycycline Plus Placebo in Patients With Rocky Mountain Spotted Fever","status":"UNKNOWN","sponsor":"Hospital General de Mexicali","startDate":"2022-05-12","conditions":"Rocky Mountain Spotted Fever","enrollment":86},{"nctId":"NCT03474276","phase":"PHASE3","title":"Comparing Several Strategies to Manage Moderate Acute Malnutrition Among Children From 6 to 24 Months Old","status":"COMPLETED","sponsor":"Institut Pasteur","startDate":"2018-01-31","conditions":"Moderate Acute Malnutrition","enrollment":1357},{"nctId":"NCT05302947","phase":"","title":"COVID-19 Study at the Russian Clinical and Research Center of Gerontology of the Pirogov RNRMU","status":"COMPLETED","sponsor":"Pirogov Russian National Research Medical University","startDate":"2020-02-01","conditions":"COVID-19, Mild to Moderate","enrollment":154},{"nctId":"NCT04374539","phase":"PHASE2","title":"Plasma Exchange in Patients With COVID-19 Disease and Invasive Mechanical Ventilation: a Randomized Controlled Trial","status":"TERMINATED","sponsor":"Fundacion Clinic per a la Recerca Biomédica","startDate":"2020-04-29","conditions":"Coronavirus","enrollment":36},{"nctId":"NCT04394182","phase":"NA","title":"Ultra Low Doses of Therapy With Radiation Applicated to COVID-19","status":"SUSPENDED","sponsor":"Fundacion GenesisCare","startDate":"2020-04-21","conditions":"Pneumonia, Viral, Cytokine Storm","enrollment":15},{"nctId":"NCT04553406","phase":"PHASE2","title":"Safety, Tolerability, Pharmacokinetics and Efficacy of SPR720 for the Treatment of Patients With Mycobacterium Avium Complex (MAC) Pulmonary Disease","status":"TERMINATED","sponsor":"Spero Therapeutics","startDate":"2020-12-03","conditions":"Mycobacterium Avium Complex, Non-tuberculous Mycobacterium Pulmonary Disease","enrollment":2},{"nctId":"NCT04338698","phase":"PHASE3","title":"Hydroxychloroquine, Oseltamivir and Azithromycin for the Treatment of COVID-19 Infection: An RCT","status":"COMPLETED","sponsor":"Shehnoor Azhar","startDate":"2020-04-22","conditions":"COVID 19","enrollment":550},{"nctId":"NCT05169255","phase":"PHASE3","title":"Impact of Prolonged Antibiotic Therapy on Commensal Microbial Community Gene Expression.","status":"COMPLETED","sponsor":"University of California, San Diego","startDate":"2012-12-07","conditions":"Microbial Colonization","enrollment":60},{"nctId":"NCT00754949","phase":"PHASE3","title":"Comparative Study of AzaSite Plus Compared to AzaSite Alone and Dexamethasone Alone to Treat Subjects With Blepharoconjunctivitis","status":"WITHDRAWN","sponsor":"Sun Pharmaceutical Industries Limited","startDate":"","conditions":"Blepharoconjunctivitis","enrollment":""},{"nctId":"NCT00578955","phase":"PHASE3","title":"Comparative Study of AzaSite Plus Compared to AzaSite Alone and Dexamethasone Alone to Treat Subjects With Blepharoconjunctivitis","status":"COMPLETED","sponsor":"Sun Pharmaceutical Industries Limited","startDate":"2007-12","conditions":"Blepharoconjunctivitis","enrollment":417},{"nctId":"NCT05118984","phase":"PHASE4","title":"Efficacy of Azithromycin in MSAF Cases to Improve Maternal and Neonatal Outcomes","status":"COMPLETED","sponsor":"Cairo University","startDate":"2021-02-16","conditions":"Meconium Stained, Azithromycin, Postpartum Endometritis","enrollment":324},{"nctId":"NCT05026801","phase":"PHASE3","title":"Azithromycin Plus Hydroxychloroquine for COVID-19 Infection","status":"WITHDRAWN","sponsor":"Iterum Therapeutics, International Limited","startDate":"2021-02-08","conditions":"Respiratory Tract Infection Viral","enrollment":""},{"nctId":"NCT04354597","phase":"NA","title":"Hydroxychloroquine and Azithromycin as Prophylaxis for Healthcare Workers Dealing With COVID19 Patients","status":"WITHDRAWN","sponsor":"King Hussein Cancer Center","startDate":"2020-05-01","conditions":"COVID-19","enrollment":""},{"nctId":"NCT01432080","phase":"PHASE2","title":"Steroids, Azithromycin, Montelukast, and Symbicort (SAMS) for Viral Respiratory Tract Infection Post Allotransplant","status":"TERMINATED","sponsor":"Maisonneuve-Rosemont Hospital","startDate":"2011-09","conditions":"Respiratory Tract Infections, Bronchiolitis Obliterans, Cryptogenic Organizing Pneumonia","enrollment":12},{"nctId":"NCT04346693","phase":"PHASE3","title":"An Open Randomized Study of Dalargin Efectiveness in Combination With Leitragin Drug in Patients With Severe and Critical Manifestations of SARS-COVID-19","status":"COMPLETED","sponsor":"Burnasyan Federal Medical Biophysical Center","startDate":"2020-04-08","conditions":"Acute Respiratory Tract Infection, Acute Respiratory Insufficiency, Pneumonia","enrollment":320},{"nctId":"NCT04358081","phase":"PHASE3","title":"Hydroxychloroquine Monotherapy and in Combination With Azithromycin in Patients With Moderate and Severe COVID-19 Disease","status":"COMPLETED","sponsor":"Novartis Pharmaceuticals","startDate":"2020-05-01","conditions":"Covid-19","enrollment":20},{"nctId":"NCT02336516","phase":"NA","title":"Azithromycin in Post Diarrheal Haemolytic and Uremic Syndrome","status":"COMPLETED","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2015-07","conditions":"Haemolytic and Uremic Syndrome","enrollment":148},{"nctId":"NCT04673214","phase":"PHASE3","title":"Evaluation of Prognostic Modification in COVID-19 Patients in Early Intervention Treatment","status":"COMPLETED","sponsor":"Gilberto Cruz Arteaga","startDate":"2020-12-16","conditions":"Covid19","enrollment":114},{"nctId":"NCT04353180","phase":"PHASE3","title":"Assessment the Activity Value of Isotretinoin (13- Cis-Retinoic Acid ) in the Treatment of COVID-19 ( Isotretinoin in Treatment of COVID-19) (Randomized)","status":"UNKNOWN","sponsor":"Kafrelsheikh University","startDate":"2021-08","conditions":"COVID19","enrollment":100000},{"nctId":"NCT03618108","phase":"PHASE2","title":"Anti-chlamydophila Antibiotic Combination Therapy in the Treatment of Patients With Coronary Heart Disease","status":"TERMINATED","sponsor":"Cadrock Pty. Ltd.","startDate":"2018-04-04","conditions":"Coronary Heart Disease, Chlamydophila Pneumoniae Infections","enrollment":20},{"nctId":"NCT04380818","phase":"NA","title":"Low Dose Anti-inflammatory Radiotherapy for the Treatment of Pneumonia by COVID-19","status":"UNKNOWN","sponsor":"Grupo de Investigación Clínica en Oncología Radioterapia","startDate":"2020-06-05","conditions":"Pneumonia, Viral","enrollment":106},{"nctId":"NCT03530319","phase":"NA","title":"Treatment of Macrolide-resistant Mycoplasma Pneumoniae","status":"UNKNOWN","sponsor":"National Taiwan University Hospital","startDate":"2018-11-10","conditions":"Pneumonia, Mycoplasma","enrollment":100},{"nctId":"NCT04322396","phase":"PHASE2","title":"Proactive Protection With Azithromycin and hydroxyChloroquine in Hospitalized Patients With COVID-19","status":"TERMINATED","sponsor":"Chronic Obstructive Pulmonary Disease Trial Network, Denmark","startDate":"2020-04-06","conditions":"Virus Diseases, Infection Viral, Corona Virus Infection","enrollment":117},{"nctId":"NCT04154722","phase":"PHASE4","title":"Comparison of Two Drugs Regimen in Treatment of Complicated Typhoid Fever in Children","status":"COMPLETED","sponsor":"Ziauddin University","startDate":"2019-06-20","conditions":"Typhoid Fever","enrollment":126},{"nctId":"NCT04595136","phase":"PHASE1, PHASE2","title":"Study to Evaluate the Efficacy of COVID19-0001-USR in Patients With Mild/or Moderate COVID-19 Infection in Outpatient","status":"UNKNOWN","sponsor":"United Medical Specialties","startDate":"2020-11-02","conditions":"SARS-CoV-2 Infection","enrollment":60},{"nctId":"NCT03268902","phase":"PHASE2, PHASE3","title":"Early Life Interventions for Childhood Growth and Development In Tanzania","status":"COMPLETED","sponsor":"Haydom Lutheran Hospital","startDate":"2017-09-05","conditions":"Malnutrition, Stunting, Cognitive Development","enrollment":1188},{"nctId":"NCT04332094","phase":"PHASE2","title":"Clinical Trial of the Use of Tocilizumab for Treatment of SARS-CoV-2 Infection (COVID-19)","status":"UNKNOWN","sponsor":"Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau","startDate":"2020-04-02","conditions":"COVID-19","enrollment":276},{"nctId":"NCT03545373","phase":"PHASE3","title":"Accuracy and Consequences of Using Trial-of-antibiotics for TB Diagnosis (ACT-TB Study)","status":"COMPLETED","sponsor":"London School of Hygiene and Tropical Medicine","startDate":"2019-02-25","conditions":"Tuberculosis, Respiratory Tract Infections, Pneumonia","enrollment":1583},{"nctId":"NCT04365582","phase":"PHASE3","title":"OUTpatient Treatment of COVID-19 in Patients With Risk Factor for Poor Outcome","status":"WITHDRAWN","sponsor":"Fondation Hôpital Saint-Joseph","startDate":"2020-05-07","conditions":"COVID","enrollment":""},{"nctId":"NCT04160026","phase":"PHASE4","title":"Acceptability and Feasibility in the Context of the IMPROVE Trial in Kenya","status":"COMPLETED","sponsor":"Liverpool School of Tropical Medicine","startDate":"2019-11-11","conditions":"Malaria in Pregnancy, Adherence, Treatment","enrollment":1600},{"nctId":"NCT04150250","phase":"PHASE2","title":"Cholera Anti-Secretory Treatment Trial","status":"COMPLETED","sponsor":"PATH","startDate":"2019-11-04","conditions":"Cholera","enrollment":47},{"nctId":"NCT01560962","phase":"NA","title":"Efficacy of Over the Counter (OTC) Povidone-Ioldine 5% for Treatment of Acute or Chronic Blepharitis","status":"TERMINATED","sponsor":"Southern California Institute for Research and Education","startDate":"2012-01","conditions":"Blepharitis","enrollment":100},{"nctId":"NCT04349592","phase":"NA","title":"Hydroxychloroquine With or Without Azithromycin for Virologic Cure of COVID-19","status":"COMPLETED","sponsor":"Hamad Medical Corporation","startDate":"2020-04-14","conditions":"Covid19","enrollment":456},{"nctId":"NCT04347031","phase":"PHASE2, PHASE3","title":"A Study of the Effectiveness of an Off Label Mefloquine Use for the Treatment of Patients With COVID19","status":"COMPLETED","sponsor":"Burnasyan Federal Medical Biophysical Center","startDate":"2020-04-08","conditions":"Pneumonia, Viral, Respiratory Failure","enrollment":320},{"nctId":"NCT04047849","phase":"PHASE4","title":"Latency Antibiotics in Previable PPROM, 18 0/7- 22 6/7 WGA","status":"RECRUITING","sponsor":"Woman's","startDate":"2019-08-28","conditions":"Rupture of Membranes; Delayed Delivery (Following Spontaneous Rupture), Rupture of Membranes; Premature, Rupture of Membranes; Premature, Affecting Fetus","enrollment":34},{"nctId":"NCT03079388","phase":"NA","title":"Nutritional and Anti-infective Interventions for Malnutrition in Pregnancy (Beleuman Welbodi)","status":"COMPLETED","sponsor":"Washington University School of Medicine","startDate":"2017-02-27","conditions":"Pregnancy, Malnutrition in Pregnancy, Nutrition Disorders","enrollment":1489},{"nctId":"NCT01778634","phase":"PHASE2","title":"Trial of Intravenous Azithromycin to Eradicate Ureaplasma Respiratory Tract Infection in Preterm Infants","status":"COMPLETED","sponsor":"University of Maryland, Baltimore","startDate":"2013-07","conditions":"Ureaplasma Infections","enrollment":121},{"nctId":"NCT04365231","phase":"PHASE3","title":"Hydroxychloroquine Azithromycin COVID-19 Pregnancy Trial","status":"WITHDRAWN","sponsor":"Hospital St. Joseph, Marseille, France","startDate":"2020-04-01","conditions":"COVID19","enrollment":""},{"nctId":"NCT04349410","phase":"PHASE2, PHASE3","title":"The Fleming [FMTVDM] Directed CoVid-19 Treatment Protocol","status":"COMPLETED","sponsor":"The Camelot Foundation","startDate":"2020-04-11","conditions":"CoVid 19 Positive","enrollment":1800},{"nctId":"NCT04542694","phase":"PHASE3","title":"Study of Favipiravir Compared to Standard of Care in Hospitalized Patients With COVID-19","status":"COMPLETED","sponsor":"Promomed, LLC","startDate":"2020-05-21","conditions":"COVID-19","enrollment":200},{"nctId":"NCT04371406","phase":"PHASE3","title":"Efficacy of Azithromycin-associated Hydroxychloroquine Therapy Given in General Practice in Early-stage Disease in COVID-19 Patients","status":"WITHDRAWN","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2020-04","conditions":"Covid-19","enrollment":""},{"nctId":"NCT04395768","phase":"PHASE2","title":"International ALLIANCE Study of Therapies to Prevent Progression of COVID-19","status":"UNKNOWN","sponsor":"National Institute of Integrative Medicine, Australia","startDate":"2020-09-09","conditions":"COVID19","enrollment":200},{"nctId":"NCT04392128","phase":"PHASE2","title":"Study Evaluating the Efficacy of Hydroxychloroquine and Azithromycine in Patients With COVID-19 and Hematological Malignancies (HYACINTHE)","status":"WITHDRAWN","sponsor":"Institut de cancérologie Strasbourg Europe","startDate":"2020-09-02","conditions":"COVID19, Hematologic Malignancy","enrollment":""},{"nctId":"NCT02003911","phase":"PHASE4","title":"Azithromycin for Children Hospitalized With Asthma","status":"TERMINATED","sponsor":"Montefiore Medical Center","startDate":"2013-10","conditions":"Asthma","enrollment":159},{"nctId":"NCT04502342","phase":"PHASE2","title":"Add on to Azythromycine, Phytomedicine and/or Antimalarial Drug vs Hydroxychloroquine in Uncomplicated COVID-19 Patients","status":"UNKNOWN","sponsor":"Institute for Research and Development of Medicinal and Food Plants of Guinea","startDate":"2020-06-01","conditions":"Covid19","enrollment":30},{"nctId":"NCT04501965","phase":"PHASE2","title":"Phytomedicines Versus Hydroxychloroquine as an Add on Therapy to Azythromycin in Asymptomatic Covid-19 Patients","status":"UNKNOWN","sponsor":"Institute for Research and Development of Medicinal and Food Plants of Guinea","startDate":"2020-06-01","conditions":"Covid19","enrollment":231},{"nctId":"NCT02707523","phase":"PHASE2","title":"Prospective Pilot Clinical Trial of Azithromycin Treatment In Respiratory Syncytial Virus (RSV)- Induced Respiratory Failure In Children","status":"COMPLETED","sponsor":"University of Alabama at Birmingham","startDate":"2016-01-01","conditions":"Respiratory Syncytial Virus","enrollment":48},{"nctId":"NCT04020380","phase":"PHASE2","title":"Azithromycin a Treatment for Pulmonary Sarcoidosis","status":"COMPLETED","sponsor":"Hull University Teaching Hospitals NHS Trust","startDate":"2019-09-06","conditions":"Sarcoidosis, Pulmonary","enrollment":21},{"nctId":"NCT04395170","phase":"PHASE2, PHASE3","title":"Convalescent Plasma (PC) and Human Intravenous Anti-COVID-19 Immunoglobulin (IV Anti COVID-19 IgG) in Patients Hospitalized for COVID-19.","status":"UNKNOWN","sponsor":"Lifefactors Zona Franca, SAS","startDate":"2020-09","conditions":"Coronavirus Disease 2019 (COVID-19)","enrollment":75},{"nctId":"NCT04461925","phase":"PHASE1, PHASE2","title":"Treatment of Coronavirus COVID-19 Pneumonia (Pathogen SARS-CoV-2) With Cryopreserved Allogeneic P_MMSCs and UC-MMSCs","status":"UNKNOWN","sponsor":"Institute of Cell Therapy","startDate":"2020-05-02","conditions":"COVID-19 Pneumonia","enrollment":30},{"nctId":"NCT04344457","phase":"PHASE1, PHASE2","title":"Evaluate the Efficacy and Safety of Oral Hydroxychloroquine, Indomethacin and Zithromax in Subjects With Mild Symptoms of COVID-19","status":"UNKNOWN","sponsor":"Perseverance Research Center, LLC","startDate":"2020-04-16","conditions":"COVID-19","enrollment":80}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":5,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"marketed","status":"active","brandName":"Azithromycin 3 days","genericName":"Azithromycin 3 days","companyName":"University of Oxford","companyId":"university-of-oxford","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Azithromycin is a macrolide antibiotic that inhibits bacterial protein synthesis by binding to the 50S ribosomal subunit. Used for Acute bacterial infections (respiratory tract infections, otitis media, sinusitis), Sexually transmitted infections (chlamydia, gonorrhea), Community-acquired pneumonia.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}